Scholarly Activity

Research is an important component of our ID fellowship training program. There are immense research opportunities at the University of Maryland. The University provides a fertile environment for research in the field of infectious diseases with the home of various institutes and centers (e.g., the Institute of Human Virology, the Institute of Global Health, the Center for Vaccine Development, the Institute of Genome Sciences, etc.)

All fellows are expected to participate in a research project as a component of their education.   Each fellow may choose a project that may be clinical, translational, or laboratory based. The choice is typically based on the fellow's individual career interests. Fellows meet with the program director or assistant program director in their first year to determine where their interests in the field of ID lie and are then referred to appropriate potential mentors as needed.

*Fellows are noted in bold and underlined*

Clinical Research

Harris AD, Jackson SS, Robinson G, Pineles L, Leekha S, Thom KA, Wang Y, Doll M, Pettigrew MM, Johnson JK. Pseudomonas aeruginosa colonization in the intensive care unit: prevalence, risk factors, and clinical outcomes. Infect Control Hosp Epidemiol. 2016;37(5):544-8.

Croft L, Ladd J, Doll M, Morgan DJ. Inappropriate antibiotic use and gastric acid suppression preceding Clostridium difficile infection. Infect Control Hosp Epidemiol. 2016;37(4):494-5.

Riedel DJ, Cox ER, Stafford KA, Gilliam BL. Clinical presentation and outcomes of prostate cancer in an urban cohort of predominantly African-American, HIV-infected patients. Urology 2015;85(2):415-22.

Fisher LH, Stafford KA, Fantry LE, Gilliam BL, Riedel DJ. Cancer Knowledge and Opportunities for Education Among HIV-Infected Patients in an Urban Academic Medical Center. J Cancer Educ. 2015;30(2):319-26.

Gilliams EA, Jumare J, Claassen CW, Thesing PC, Nyirenda OM, Dzinjalamala FK, Taylor T, Plowe CV, Tracy LA, Laufer MK.  Chloroquine-azithromycin combination antimalarial treatment decreases risk of respiratory- and gastrointestinal-tract infections in Malawian children. J Infect Dis. 2014; 210:585-92.

Osinusi-Adekanmbi O, Stafford K, Ukpaka A, Salami D, Ajayi S, Ndembi N, Abimiku A, Nwizu C, Gilliam B, Redfield R, Amoroso A. Long-term outcome of second-line antiretroviral therapy in resource-limited settings. J Int Assoc Provid AIDS Care. 2014;13:366-71.

Arnold R, Rock C, Croft L, Gilliam BL, Morgan DJ. Factors associated with treatment failure in vertebral osteomyelitis requiring spinal instrumentation. Antimicrob Agents Chemother. 2014 Feb;58(2):880-4.

Majid A, McAninch J, Morgan DJ, El Kamary SS, Zhan M, Kapelusznik L, Talwani R.  Predictors of early treatment discontinuation in a cohort of patients treated with boceprevir-based therapy for hepatitis C infection. J Viral Hepat. 2013;21(8):585-9

Forrest GN, Arnold RS, Gammie JS, Gilliam BL.  Single center experience of a vancomycin resistant enterococcal endocarditis cohort. J Infect. 2011 Dec;63(6):420-8.

Furuno JP, Johnson JK, Schweizer ML, Uche A, Stine OC, Shurland SM, Forrest GN.  Community-associated methicillin-resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: a cohort study.  BMC Infect Dis. 2011 Oct 31;11:298.

Chi BH, Mwango A, Giganti MJ, Sikazwe I, Moyo C, Schuttner L, Mulenga LB, Bolton-Moore C, Chintu NT, Sheneberger R, Stringer EM, Stringer JS.  Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):475-81.

Carr JK, Osinusi A, Flynn CP, Gilliam BL, Maheshwari V, Zhao RY. Two independent epidemics of HIV in Maryland. J Acquir Immune Defic Syndr. 2010 Jul;54(3):297-303.

Forrest GN, Kopack AM, Perencevich EN. Statins in candidemia: clinical outcomes from a matched cohort study. BMC Infect Dis. 2010 Jun 4;10:152.

Osinusi A, Rasimas JJ, Bishop R, Proschan M, McLaughlin M, Murphy A, Cortez KJ, Polis MA, Masur H, Rosenstein D, Kottilil S. HIV/Hepatitis C virus-coinfected virologic responders to pegylated interferon and ribavirin therapy more frequently incur interferon-related adverse events than nonresponders do. J Acquir Immune Defic Syndr. 2010 Mar;53(3):357-63.

Sajadi MM, Roddy KM, Chan-Tack KM, Forrest GN.  Risk factors for mortality from primary cryptococcosis in patients with HIV.  Postgrad Med. 2009 Mar;121(2):107-13.

Thom KA, Shardell MD, Osih RB, Schweizer ML, Furuno JP, Perencevich EN, McGregor JC, Harris AD.  Controlling for severity of illness in outcome studies involving infectious diseases: impact of measurement at different time points. Infect Control Hosp Epidemiol. 2008;29(11):1048-53.

Thom KA, Schweizer ML, Osih RB, McGregor JC, Furuno JP, Perencevich EN, Harris AD.  Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study. BMC Infect Dis. 2008 Sep 15;8:116.

Riedel DJ, Weekes E, Forrest GN.  Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus. Antimicrob Agents Chemother. 2008 Jul;52(7):2463-7. 

Osih RB, McGregor JC, Rich SE, Moore AC, Furuno JP, Perencevich EN, Harris AD.  Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia.  Antimicrob Agents Chemother. 2007 Mar;51(3):839-44.

Laboratory Research

Bork JT, Leekha S, Heil EL, Zhao L, Badamas R, Johnson JK. Rapid testing using the Verigene Gram-negative blood culture nucleic acid test in combination with antimicrobial stewardship intervention against Gram-negative bacteremia. Antimicrob Agents Chemother. 2015;59(3):1588-95.

Maldarelli GA, De Masi L, von Rosenvinge EC, Carter M, Donnenberg MS.  Identification, immunogenicity, and cross-reactivity of type IV pilin and pilin-like proteins from Clostridium difficile. Pathog Dis. 2014;71:302-14.

Saharia KK, Koup RA. T cell susceptibility to HIV influences outcome of opportunistic infections. Cell. 2013;155(3):505-14.

Feng C, Zhang L, Nguyen C, Vogel SN, Goldblum SE, Blackwelder WC, Cross AS.  Neuraminidase reprograms lung tissue and potentiates lipopolysaccharide-induced acute lung injury in mice. J Immunol. 2013;191(9):4828-37.

Cross AS, Hyun SW, Miranda-Ribera A, Feng C, Liu A, Nguyen C, Zhang L, Luzina IG, Atamas SP, Twaddell WS, Guang W, Lillehoj EP, Puché AC, Huang W, Wang LX, Passaniti A, Goldblum SE. NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not.  J Biol Chem. 2012;287(19):15966-80.

Lillehoj EP, Hyun SW, Feng C, Zhang L, Liu A, Guang W, Nguyen C, Luzina IG, Atamas SP, Passaniti A, Twaddell WS, Puché AC, Wang LX, Cross AS, Goldblum SE.  NEU1 sialidase expressed in human airway epithelia regulates epidermal growth factor receptor (EGFR) and MUC1 protein signaling.  J Biol Chem. 2012;287(11):8214-31.

Nguyen C, Feng C, Zhan M, Cross AS, Goldblum SE.  Bacillus anthracis-derived edema toxin (ET) counter-regulates movement of neutrophils and macromolecules through the endothelial paracellular pathway. BMC Microbiol. 2012;12:2.

Riedel DJ, Sajadi MM, Armstrong CL, Cummings JS, Cairo C, Redfield RR, Pauza CD.  Natural viral suppressors of HIV-1 have a unique capacity to maintain gamma delta T cells.  AIDS. 2009;23(15):1955-64.

Bordon J, Evans PS, Propp N, Davis CE Jr, Redfield RR, Pauza CD.  Association between longer duration of HIV-suppressive therapy and partial recovery of the V gamma 2 T cell receptor repertoire.  J Infect Dis. 2004 Apr 15;189(8):1482-6.

Case Reports

Shah J, Poonawala H, Keay SK, Serulle Y, Steven A, Gandhi D, Cole JW. Varicella-Zoster Virus Vasculopathy: A Case Report Demonstrating Vasculitis using Black-Blood MRI. J Neurol Neurophysiol. 2015;6(6).

Bork JT, Macharia T, Choi J, Gilliam BL, Buchwald UK. Syphilitic Hepatitis treated with Doxycycline in an HIV-infected Patient and Review of the Literature. Sex Transm Dis 2014;41(8):507-510.

Cox ER, Nayak SU, Kuruppu JC.  Klebsiella oxytoca bacteremia-causal relationship to symptomatic colitis? Int J Infect Dis. 2013 Jun;17(6):e472-3.

Sachdev SH, Joshi V, Cox ER, Amoroso A, Palekar S. Severe life-threatening Ehrlichia chaffeensis infections transmitted through solid organ transplantation. Transpl Infect Dis. 2014;16(1):119-24.

Taremi M, Amoroso A, Nace HL, Gilliam BL.  Influenza B-induced refractory cardiogenic shock: a case report. BMC Infect Dis. 2013;13:452.

Osinusi A, Kleiner D, Wood B, Polis M, Masur H, Kottilil S.  Rapid development of advanced liver fibrosis after acquisition of hepatitis C infection during primary HIV infection. AIDS Patient Care STDS. 2009;23(6):403-6.

Cox ER, Amoroso A, Gilliam BL. Pannus attack: septic thrombophlebitis. Am J Med. 2012;125(12):1175-7.

Roddy K, Kao G, Dawn M, Bock J, Riedel D, Gilliam B. The arthritic fisherman. Am J Med. 2008 Apr;121(4):287-9.

Riedel DJ, Talwani R, Gilliam BL. Double trouble. Am J Med. 2008 Feb;121(2):110-2.

Polk C, Chan-Tack KM, Kopack AM, Amoroso A. Induction therapy with enfuvirtide-based highly active antiretroviral therapy in a patient with acute HIV-1 infection. AIDS Patient Care STDS. 2007;21(2):75-7.

Chan-Tack KM, Ahuja N, Weinman EJ, Wali RK, Uche A, Greisman LA, Drachenberg C, Hawkins PN, Redfield RR.  Acute renal failure and nephrotic range proteinuria due to amyloidosis in an HIV-infected patient.  Am J Med Sci. 2006;332(6):364-7.

Chan-Tack KM, Edozien A.  Lamivudine monotherapy in an HIV-infected patient with the M184V mutation.  J Int Assoc Physicians AIDS Care (Chic). 2006;5(3):121-2.

Photo Cases

Doll M, Kleinberg M, Kokh D, Riedel DJ. Loss of Virologic Control and Severe Pneumocystis pneumonia in an HIV-Infected Patient Receiving Chemotherapy for Non-Small Cell Lung Cancer. AIDS Res Hum Retroviruses. 2016;32(1):4-5.

Fisher LH, Choi J, Bricker RS, Shere-Wolfe KD, Saharia K. Daptomycin-induced eosinophilic pneumonia. Clin Infect Dis. 2015;61(6):978-9, 1026-7.

Bork JT, Wilding E, Claassen CW, Johnson JK, Kleinberg M. Fungal sinusitis in a 75-year-old neutropenic cancer patient. Clin Infect Dis. 2015;60(2):274; answer 321-2.

Schmalzle SA, Wolde-Rufael D, Gilliam BL. Diarrhea, anasarca, and severe hypoalbuminemia in an AIDS patient. Diagnosis: AIDS-related visceral Kaposi sarcoma (KS) with protein-losing enteropathy (PLE). Clin Infect Dis. 2015;60(8):1241, 1281-3.

Rock C, Thom K. Ecthyma gangrenosum caused by Pseudomonas aeruginosa. J Am Osteopath Assoc. 2012 Apr;112(4):240.

Osinusi O, Greisman L, Menajovsky J, Pinczewski J, Ghosh M.  A patient with AIDS with fungating lesions of the face and scalp.  Clin Infect Dis. 2011 Apr 15;52(8):1029-30, 1077-8. doi: 10.1093/cid/cir030

Weld ED, Eimer KM, Saharia K, Orenstein A, Hess JR.  Transfusion medicine illustrated. The expanding range and severity of babesiosis.  Transfusion. 2010 Feb;50(2):290-1.

Riedel DJ, Nugent SL, Gilliam BL.  Upper gastrointestinal bleeding in a patient with HIV infection.  Clin Infect Dis. 2009 Feb 1;48(3):321, 368-9. doi: 10.1086/595849. 

Riedel DJ, Roddy KM, Sajadi MM.  Abdominal pain and bacterial meningitis in a previously healthy young adult.  Clin Infect Dis. 2008 May 1;46(9):1458, 1479-80. doi: 10.1086/587065. 

Carpenter M, Polk C, Castellani R, Mochoruk K, Sanche S, Stern B, Donnenberg MS.  Encephalitis of the basal ganglia in an injection drug user.  Clin Infect Dis. 2007 Dec 1;45(11):1479, 1522-4. 

Polk C, Forrest G, Cross A.  Cellulitis in a patient with leukemia.  Clin Infect Dis. 2007 May 1;44(9):1220-1, 1249-50.

Henn SL, Forrest GN.  Febrile neutropenia associated with painful lesions of the palms and digits.  Clin Infect Dis  2006 Sep 15; 43(6):791-792.


Schmalzle S, Buchwald UK, Gilliam BL, Riedel DJ. Cryptococcus neoformans infection in malignancy. Mycoses 2016 Mar 2. [Epub ahead of print].
D'Angelo RG, Johnson JK, Bork JT, Heil EL. Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria. Expert Opin Pharmacother. 2016;17(7):953-67.

Heil EL, Hynicka LM, Kottilil S, Tang L. What does the pharmacological future of treating chronic hepatitis C look like? Expert Rev Clin Pharmacol. 2015;8(5):605-22.

Doll M, Morgan DJ, Anderson D, Bearman G. Touchless Technologies for Decontamination in the Hospital: a Review of Hydrogen Peroxide and UV Devices. Curr Infect Dis Rep. 2015;17(9):498.

Donnenberg MS, Narayanan S. How to diagnose a foodborne illness.  Infect Dis Clin North Am. 2013 Sep;27(3):535-54.

Majid A, Redfield RR, Gilliam BL. The use of preexposure treatments for HIV prophylaxis. HIV AIDS (Auckl). 2012;4:17-28.

Arnold RS, Thom KA, Sharma S, Phillips M, Johnson K, Morgan DJ.  Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria. South Med J. 2011;104(1):40-5.

Chua JV, Chen WH. Herpes zoster vaccine for the elderly: boosting immunity. Aging health. 2010;6(2):169-176.

Chua JV, Chen WH. Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks. Crit Care. 2010;14(2):218. 

Riedel DJ, Gonzalez-Cuyar LF, Zhao XF, Redfield RR, Gilliam BL.  Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection. Lancet Infect Dis. 2008;8(4):261-7.

McGregor JC, Rich SE, Harris AD, Perencevich EN, Osih R, Lodise TP Jr, Miller RR, Furuno JP.  A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis. 2007;45(3):329-37.

Stein M, Caplan ES.  Nosocomial sinusitis: a unique subset of sinusitis. Curr Opin Infect Dis. 2005;18(2):147-50. 

Book Chapters

In: Wright WF, ed. Essentials of Clinical Infectious Diseases, Demos Medical Publishing, New York, NY, 2013.

  • Husson J, Wright WF.  Endocarditis. p. 51-58.
  • Cox E, Thom KA. Infections Involving Intravascular Catheters. p. 70-76.
  • Luizaga G, Kapelusznik L, Wright WF. Empyema. p. 89-95.
  • Majid A, Buchwald UK, Patel D. Lung Abscess.  p. 96-101.
  • Keckich D, Buchwald UK.  Tuberculosis. p. 102-111.
  • Arnold RS, Wright WF.  Clostridium difficile colitis.  p. 144-149.
  • Bailey J, Kuruppu JC, Wright WF.  Pyelonephritis and Renal Abscess.  p. 191-198.
  • Rock C, Thom KA, Wright WF. Catheter-Related Urinary Tract Infections.  p. 199-204.
  • Cox E, Sowah LA.  Sexually Transmitted Diseases. p. 267-275.
  • Narayanan S, Delva G, Redfield RR, Gilliam BL.  HIV and AIDS. p. 276-297.
  • Husson J, Sowah L.  Obstetrics and Gynecology-Related Infections.  p. 299-309.
  • Bailey J, Amoroso A, Wright WF.  Infectious Keratitis. p. 311-317.
  • Majid A, Amoroso A, Wright WF.  Endophthalmitis. p. 318-324.
  • Vaz J, Patel DM, Wright WF.  Systemic Inflammatory Response Syndrome and Sepsis. p. 325-334.
  • Tablang M, Riedel DJ.  Hematopoietic Stem Cell Transplant Infections. p. 335-340.
  • Tablang M, Davis CE. Solid Organ Transplant Infections. p. 341-348.
  • Rock C, Leekha S.  Basic Approach to Infection Control and Epidemiology. p. 349-355.

In: Hardy D, ed. AAHIVM Fundamentals of HIV Medicine, 2012 Edition, American Academy of HIV Medicine, Washington DC, 2012.

  • Majid A, Gilliam BL.  Future Antiretrovirals and Immune-based Strategies (Therapeutic and Preventive Vaccines).  p. 427-446.

In: Fratamico PM, Smith JL, Brogden K, ed. Sequelae and Long-Term Consequences of Infectious Disease.  American Society for Microbiology, Washington, DC, 2009.

  • Lorenz BD, Donnenberg MS.  Escherichia coli: Enteric and Extraintestinal Infections. p. 69 - 85.